Leonteq Securities’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Leonteq Securities's NVO Position: Q3 2026 in Review
Leonteq Securities reduced its Novo Nordisk (NVO) stake by 80% in Q3 2026, selling an estimated $1.06M and leaving 5,829 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #487.
Leonteq Securities first reported a position in NVO in Q4 2020 and has held it in 22 quarters since. The position peaked at $22.1M in Q2 2025. 1,220 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Leonteq Securities held 5,829 shares of Novo Nordisk worth $221K as of Q3 2026.
- Leonteq Securities sold 22,967 Novo Nordisk shares in Q3 2026, an estimated $1.06M.
- Novo Nordisk made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #487 holding.
- Leonteq Securities first reported a position in Novo Nordisk in Q4 2020 and has held it in 22 quarters since.
- Leonteq Securities's Novo Nordisk position peaked at $22.1M in Q2 2025.
- 1,220 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.